Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age
佐剂灭活脊髓灰质炎疫苗IPV-Al与标准IPV的免疫原性和安全性比较：一项在6、10、14周和9月龄婴儿中开展的3期观察者盲法、随机、对照试验
期刊:
影响因子:
doi:10.1016/j.vaccine.2019.10.064
Bravo, Lulu C; Carlos, Josefina C; Gatchalian, Salvacion R; Montellano, May Emmeline B; Tabora, Charissa Fay Corazon B; Thierry-Carstensen, Birgit; Tingskov, Pernille Nyholm; Sørensen, Charlotte; Wachmann, Henrik; Bandyopadhyay, Ananda S; Nielsen, Pernille Ingemann; Kusk, Mie Vestergaard
